Presentation slides and video from the 2021-2022 Advances in Cancer Immunotherapy™: A Focus on Immune Checkpoint Inhibitors held virtually on April 23, 2022 are available here.Program Organizers
Program Summary
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are half-day innovative programs will have the opportunity for in-depth training in immunotherapy treatment for a variety of topics from leaders in this specific field. The ACI program also featured a discussion of closed cases submitted from attendees to hear guidance and insights from expert faculty.
Program Learning Objectives
Please note on-demand recordings are not available for continuing education credits.#AdvancesinCancerImmunotherapy(ACI)#2022#ImmuneCheckpointInhibitors#ClinicalTrials#PresentationSlides#Video
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Immune Checkpoint Inhibitors; Presenter: Sadia Ali, MD - UT Southwestern Medical Center; Bonnie Bermas, MD - UT Southwestern Medical Center; Tina Cascone, MD, PhD - The University of Texas MD Anderson Cancer Center; David E. Gerber, MD - Harold C. Simmons Comprehensive Cancer Center; Nikhil I. Khushalani, MD - Moffitt Cancer Center; Jamie S. Lin, MD, FASN - The University of Texas MD Anderson Cancer Center; Jarushka Naidoo, MBBCH, MHS - Beaumont RCSI Cancer Centre Dublin; Vickie Shannon, MD - The University of Texas MD Anderson Cancer Center; Diane Tseng, MD, PhD - University of Washington School of Medicine, Fred Hutchinson Cancer Research Center; Natalie Vokes, MD - The University of Texas MD Anderson Cancer Center; Date: April 23, 202200:40:40
Meeting: Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Immune Checkpoint Inhibitors; Presenter: Sadia Ali, MD - UT Southwestern Medical Center; Date: April 23, 202200:27:13
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Immune Checkpoint Inhibitors; Presenter: Nikhil I. Khushalani, MD - Moffitt Cancer Center; Date: April 23, 202200:24:22
Meeting: Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Immune Checkpoint Inhibitors; Presenter: Vickie Shannon, MD - The University of Texas MD Anderson Cancer Center; Date: April 23, 202200:23:05
Meeting: Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Immune Checkpoint Inhibitors; Presenter: Bonnie Bermas, MD - UT Southwestern Medical Center; Date: April 23, 202200:22:08
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Immune Checkpoint Inhibitors; Presenter: Natalie Vokes, MD - The University of Texas MD Anderson Cancer Center; Date: April 23, 202200:29:27
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Immune Checkpoint Inhibitors; Presenter: Diane Tseng, MD, PhD - University of Washington School of Medicine, Fred Hutchinson Cancer Research Center; Date: April 23, 202200:19:57
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Immune Checkpoint Inhibitors; Presenter: Jarushka Naidoo, MBBCH, MHS - Beaumont RCSI Cancer Centre Dublin; Date: April 23, 202200:22:27
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Immune Checkpoint Inhibitors; Presenter: Marina Chiara Garassino, MD - The University of Chicago; Date: April 23, 202200:20:51
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us